Pioglitazole and metformin hydrochloride
Pioglitazole and metformin hydrochloride is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Pioglitazole and metformin hydrochloride. Available dosage form: tablet.
Drug Details
- Generic Name
- Pioglitazole and metformin hydrochloride
- Brand Names
- Pioglitazole and metformin hydrochloride
- Application Number
- ANDA204802
- Sponsor
- Bryant Ranch Prepack
- NDC Codes
- 2
- Dosage Forms
- TABLET
- Routes
- ORAL
- Active Ingredients
- PIOGLITAZONE HYDROCHLORIDE, METFORMIN HYDROCHLORIDE
Indications and Usage
1 INDICATIONS & USAGE Pioglitazone and metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus Limitations of Use Pioglitazone and metformin hydrochloride tablets is not recommended to treat type 1 diabetes mellitus or diabetic ketoacidosis. Pioglitazone and metformin hydrochloride tablets are a thiazolidinedione and biguanide combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both pioglitazone and metformin is appropriate. ( 1 , 14 ) Limitations of Use : • Not for treatment of type 1 diabetes or diabetic ketoacidosis. ( 1 )